Clinical trial
A Randomized, Multiple Dose, Double Blind, 5-way Crossover Study of the…
NCT00419783 · Faes Farma, S.A., Industry · Completed
Key facts
| NCT number | NCT00419783 |
|---|---|
| Title | A Randomized, Multiple Dose, Double Blind, 5-way Crossover Study of the Electrocardiographic (ECG) Effects of Bilastine |
| Official title | A Phase 1, Randomized, Multiple Dose, Double Blind, 5-way Crossover Study of the Electrocardiographic Effects of Bilastine in Healthy Adult Subjects |
| Lead sponsor | Faes Farma, S.A., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | bilastine, Bilastine, Bilastine & Ketoconazole, Moxifloxacin, Placebo |
| Enrollment | 30 |
| Start date | Aug 1, 2006 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Jan 9, 2007 |
| Last update posted | Apr 5, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: